Sheth Radhika, Malik Devin
Internal Medicine, Henry Ford Health System, Jackson, USA.
Hematology/Oncology, Henry Ford Health System, Jackson, USA.
Cureus. 2020 Dec 18;12(12):e12147. doi: 10.7759/cureus.12147.
Retroperitoneal fibrosis (RPF) is a rare condition characterized by fibroinflammatory tissue infiltrating and compressing retroperitoneal structures. While mostly idiopathic (idiopathic retroperitoneal fibrosis or IRF), RPF is frequently associated with certain drugs, infections, and malignancies. It is thought to be immune-mediated because of response to steroids and RPF is commonly seen with other autoimmune diseases, especially IgG4-related disease (IgG4-RD). IRF is also a part of the chronic aortitis syndromes and the presence of aortic aneurysms is another characteristic of this disease. A 63-year old woman presented with left-sided flank pain. Computed tomography (CT) scan showed left hydronephrosis from compression of the ureter by a retroperitoneal mass. A thoracoabdominal aneurysm was also noted. A [F]- fluorodeoxyglucose positron emission tomography (FDG-PET) scan showed hypermetabolism in the mass, with no abnormally increased activity noted elsewhere. Within four months, the mass enlarged to involve the right ureter as well, leading to right hydronephrosis. She required bilateral ureteral stents and aneurysm repair. Biopsy of the mass showed dense fibrosis with a mononuclear cell infiltrate. The histology of the aneurysm specimen showed chronic periaortic inflammation. Laboratory investigations were significant for elevated C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), with no evidence of monoclonal gammopathy. She was referred to the rheumatology clinic to receive steroid treatment for IRF. IRF commonly involves the ureters and is diagnosed on CT scans during a workup for obstructive uropathy. The treatment is high dose steroids, while in resistant cases, other immunosuppressants have been used. The presentation of a patient with IRF can commonly mimic that of urinary calculi and malignancy. While rare, IRF should not be forgotten when evaluating a patient for obstructive uropathy.
腹膜后纤维化(RPF)是一种罕见疾病,其特征为纤维炎性组织浸润并压迫腹膜后结构。虽然大多为特发性(特发性腹膜后纤维化或IRF),但RPF常与某些药物、感染及恶性肿瘤相关。由于对类固醇有反应,故认为其由免疫介导,且RPF常见于其他自身免疫性疾病,尤其是IgG4相关疾病(IgG4-RD)。IRF也是慢性主动脉炎综合征的一部分,主动脉瘤的存在是该疾病的另一特征。一名63岁女性因左侧胁腹疼痛就诊。计算机断层扫描(CT)显示腹膜后肿块压迫输尿管导致左肾积水。还发现了胸腹主动脉瘤。[F] - 氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)显示肿块代谢活跃,其他部位未见异常活性增加。在四个月内,肿块增大并累及右侧输尿管,导致右肾积水。她需要双侧输尿管支架置入及动脉瘤修复。肿块活检显示致密纤维化伴单核细胞浸润。动脉瘤标本的组织学检查显示主动脉周围慢性炎症。实验室检查显示C反应蛋白(CRP)和红细胞沉降率(ESR)升高,无单克隆丙种球蛋白病证据。她被转诊至风湿病诊所接受IRF的类固醇治疗。IRF通常累及输尿管,在梗阻性肾病的检查过程中通过CT扫描确诊。治疗方法为大剂量类固醇,对于耐药病例,已使用其他免疫抑制剂。IRF患者的表现通常可模仿尿路结石和恶性肿瘤。虽然罕见,但在评估梗阻性肾病患者时不应忘记IRF。